- Verzenio [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
- Data on file. Lilly USA, LLC. ONC20170921a.
- Sledge GW Jr, Toi M, Neven P, et al. MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+/HER2− advanced breast cancer who had progressed while receiving endocrine therapy. J Clin Oncol. 2017;35(25):2875-2884.